Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
55.53
-0.24 (-0.43%)
At close: Apr 29, 2026

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Market Capitalization
25,83126,56417,23719,53016,03014,959
Upgrade
Market Cap Growth
26.22%54.11%-11.74%21.83%7.16%-
Upgrade
Enterprise Value
25,13725,70417,34218,89114,51814,805
Upgrade
Last Close Price
55.5357.6041.4747.8539.3737.01
Upgrade
PS Ratio
32.2433.1647.89213.94-1454.37
Upgrade
PB Ratio
19.9420.5086.1623.019.126.07
Upgrade
P/TBV Ratio
28.7829.60-50.5112.667.53
Upgrade
EV/Sales Ratio
31.3832.0848.18206.94-1439.37
Upgrade
Debt / Equity Ratio
0.960.965.790.480.050.04
Upgrade
Net Debt / Equity Ratio
-0.54-0.541.59-0.40-0.76-0.81
Upgrade
Net Debt / EBITDA Ratio
0.900.90-0.340.301.773.12
Upgrade
Net Debt / FCF Ratio
0.920.92-0.400.341.973.97
Upgrade
Asset Turnover
0.340.340.220.05-0.01
Upgrade
Inventory Turnover
0.840.840.280.54--
Upgrade
Quick Ratio
2.112.111.111.785.709.82
Upgrade
Current Ratio
2.222.221.272.035.939.96
Upgrade
Return on Equity (ROE)
-102.76%-102.76%-179.21%-84.98%-34.87%-37.83%
Upgrade
Return on Assets (ROA)
-21.71%-21.71%-37.81%-40.35%-20.52%-21.46%
Upgrade
Return on Capital Employed (ROCE)
-40.60%-40.60%-104.20%-110.20%-43.20%-26.60%
Upgrade
Earnings Yield
-2.96%-2.88%-4.91%-5.67%-4.59%-4.48%
Upgrade
FCF Yield
-2.94%-2.86%-4.57%-5.12%-4.22%-3.35%
Upgrade
Buyback Yield / Dilution
-7.75%-7.75%-1.83%-0.70%-12.29%-0.07%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.